TBC1D5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.562100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.596100E-02
Normal-vs-Stage2
4.078300E-03
Normal-vs-Stage3
9.676100E-02
Normal-vs-Stage4
1.976160E-01
Stage1-vs-Stage2
6.018200E-01
Stage1-vs-Stage3
3.070200E-02
Stage1-vs-Stage4
1.570550E-01
Stage2-vs-Stage3
1.611270E-04
Stage2-vs-Stage4
4.046200E-01
Stage3-vs-Stage4
8.981000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.220500E-03
Normal-vs-AfricanAmerican
2.413200E-01
Normal-vs-Asian
9.778900E-03
Caucasian-vs-AfricanAmerican
2.629000E-01
Caucasian-vs-Asian
6.290400E-02
AfricanAmerican-vs-Asian
1.067350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.419000E-03
Normal-vs-Female
3.724800E-03
Male-vs-Female
5.013800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.788160E-01
Normal-vs-Age(41-60Yrs)
8.363500E-03
Normal-vs-Age(61-80Yrs)
2.357600E-03
Normal-vs-Age(81-100Yrs)
2.768000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.878000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.238600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.143600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.852500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.655600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.581400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.724500E-03
Normal-vs-Daily Drinker
8.838700E-04
Normal-vs-Weekly Drinker
7.761100E-03
Normal-vs-Occasional Drinker
6.403800E-03
Normal-vs-Social Drinker
1.161640E-01
Non Drinker-vs-Daily Drinker
3.931400E-01
Non Drinker-vs-Weekly Drinker
8.567400E-01
Non Drinker-vs-Occasional Drinker
6.027400E-01
Non Drinker-vs-Social Drinker
1.345370E-01
Daily Drinker-vs-Weekly Drinker
5.677000E-01
Daily Drinker-vs-Occasional Drinker
1.638180E-01
Daily Drinker-vs-Social Drinker
3.536200E-02
Weekly Drinker-vs-Occasional Drinker
5.092800E-01
Weekly Drinker-vs-Social Drinker
1.660360E-01
Occasional Drinker-vs-Social Drinker
3.034400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.341800E-01
Normal-vs-Grade 2
9.708200E-02
Normal-vs-Grade 3
5.361900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.241800E-01
Grade 1-vs-Grade 3
1.240240E-01
Grade 1-vs-Grade 4
2.341800E-01
Grade 2-vs-Grade 3
3.910200E-01
Grade 2-vs-Grade 4
9.708200E-02
Grade 3-vs-Grade 4
5.361900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.077100E-03
Normal-vs-NonDiabetic
1.017840E-03
Diabetic-vs-NonDiabetic
8.057000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.819500E-03
Normal-vs-NoPancreatitis
1.601820E-03
Pancreatitis-vs-NoPancreatitis
4.921400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.102300E-03
Normal-vs-N1
3.964000E-03
N0-vs-N1
5.313600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.352400E-01
Normal-vs-TP53-NonMutant
2.861800E-02
TP53-Mutant-vs-TP53-NonMutant
8.346400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
